Blue Ocean Robotics has appointed PSC Biotech as its pharmaceutical sector partner to accelerate international deployment of its UVD Robot Pharma platform, with an initial focus on the United States, Australia and Singapore.
PSC Biotech, a life sciences consultancy based in California, works with pharmaceutical and biotechnology companies on regulatory compliance, validation, and quality systems in GMP-controlled environments.
The agreement positions PSC Biotech to lead distribution and implementation in these regions.
The UVD Robot Pharma system uses autonomous UV-C light disinfection cycles to deliver repeatable surface decontamination in cleanrooms, supporting contamination control while reducing reliance on manual cleaning processes.
The wider UVD Robots business was founded by the Danish robotics company in 2016, emerging from a public-private innovation project focused on reducing healthcare-associated infections and improving environmental cleaning in hospitals and controlled environments.
The core UVD Robot technology reached commercial maturity around 2020, when the company introduced its third-generation system (Model C), which became the foundation for later sector-specific variants such as the Pharma model.
The Pharma variant is a specialised version of the company’s autonomous UV-C platform designed specifically for GMP-regulated cleanrooms and pharmaceutical production environments.
It uses self-navigating robotics combined with UV-C light emitters to disinfect room surfaces by delivering measured doses of ultraviolet light in a controlled, repeatable cycle.
Through the partnership, the technology will be introduced to a broader customer base across multiple continents, supported by PSC Biotech’s regional presence and sector expertise.
Last year, the pharmaceutical giant AstraZeneca published a study showing that UV-C robots can reduce microbial contamination by more than 99.9% on cleanroom surfaces, supporting their role as an adjunct to traditional disinfection methods.